Search research articles
Contact Us
Filters
Showing results (151-160 of 215) with videos related to
Page
of 22
Sort By:
Journal of Pharmaceutical and Biomedical Analysis
|
July 25, 2009
Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry
Peter de Bruijn, Inge M Ghobadi Moghaddam-Helmantel, Maja J A de Jonge, et al.
British Journal of Pharmacology
|
January 14, 2010
Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)
H Burger, A Zoumaro-Djayoon, A W M Boersma, et al.
The Journal of Organic Chemistry
|
December 26, 2001
Elongated multiple electronic cascade and cyclization spacer systems in activatible anticancer prodrugs for enhanced drug release
F M de Groot, W J Loos, R Koekkoek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 1998
Irinotecan (CPT-11) metabolism and disposition in cancer patients
A Sparreboom, M J de Jonge, P de Bruijn, et al.
BMC Cell Biology
|
March 17, 2010
Nuclear variants of bone morphogenetic proteins
Jenny E Felin, Jaime L Mayo, Trina J Loos, et al.
World Journal of Surgery
|
August 19, 2011
Delayed primary closure of the septic open abdomen with a dynamic closure system
Froukje J Verdam, Dennis E J G J Dolmans, Maarten J Loos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 1998
Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle Cremophor EL
A I de Vos, K Nooter, J Verweij, et al.
Cancer Chemotherapy and Pharmacology
|
October 20, 2006
Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients
Walter J Loos, Ronald de Wit, Steven J Freedman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 1998
Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo
A Sparreboom, J Verweij, M E van der Burg, et al.
Clinical Pharmacology and Therapeutics
|
April 22, 2011
Environmental and genetic factors affecting transport of imatinib by OATP1A2
K Eechoute, R M Franke, W J Loos, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 215) with videos related to
Sort By:
Page
of 22
Journal of Pharmaceutical and Biomedical Analysis
|
July 25, 2009
Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry
Peter de Bruijn, Inge M Ghobadi Moghaddam-Helmantel, Maja J A de Jonge, et al.
British Journal of Pharmacology
|
January 14, 2010
Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)
H Burger, A Zoumaro-Djayoon, A W M Boersma, et al.
The Journal of Organic Chemistry
|
December 26, 2001
Elongated multiple electronic cascade and cyclization spacer systems in activatible anticancer prodrugs for enhanced drug release
F M de Groot, W J Loos, R Koekkoek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 1998
Irinotecan (CPT-11) metabolism and disposition in cancer patients
A Sparreboom, M J de Jonge, P de Bruijn, et al.
BMC Cell Biology
|
March 17, 2010
Nuclear variants of bone morphogenetic proteins
Jenny E Felin, Jaime L Mayo, Trina J Loos, et al.
World Journal of Surgery
|
August 19, 2011
Delayed primary closure of the septic open abdomen with a dynamic closure system
Froukje J Verdam, Dennis E J G J Dolmans, Maarten J Loos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 1998
Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle Cremophor EL
A I de Vos, K Nooter, J Verweij, et al.
Cancer Chemotherapy and Pharmacology
|
October 20, 2006
Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients
Walter J Loos, Ronald de Wit, Steven J Freedman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 1998
Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo
A Sparreboom, J Verweij, M E van der Burg, et al.
Clinical Pharmacology and Therapeutics
|
April 22, 2011
Environmental and genetic factors affecting transport of imatinib by OATP1A2
K Eechoute, R M Franke, W J Loos, et al.
Page
of 22